Hempstract OTC Stock Performance

HPST -  USA Stock  

USD 0.08  0.0092  10.31%

Hempstract has performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.7246, which attests to possible diversification benefits within a given portfolio. Let's try to break down what Hempstract's beta means in this case. As returns on the market increase, returns on owning Hempstract are expected to decrease at a much lower rate. During the bear market, Hempstract is likely to outperform the market. Although it is extremely important to respect Hempstract current price history, it is better to be realistic regarding the information on equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Hempstract technical indicators, you can presently evaluate if the expected return of 0.16% will be sustainable into the future. Hempstract right now retains a risk of 7.3%. Please check out Hempstract maximum drawdown, as well as the relationship between the skewness and day typical price to decide if Hempstract will be following its current trending patterns.

Hempstract O TC Stock Performance 

 Hempstract Performance
1 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Hempstract are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Hempstract may actually be approaching a critical reversion point that can send shares even higher in November 2021. ...more

Hempstract Price Channel

Quick Ratio0.65
Fifty Two Week Low0.0670
Fifty Two Week High0.8000

Hempstract Relative Risk vs. Return Landscape

If you would invest  9.50  in Hempstract on July 30, 2021 and sell it today you would lose (0.58)  from holding Hempstract or give up 6.11% of portfolio value over 90 days. Hempstract is currently generating 0.1644% in daily expected returns and assumes 7.3035% risk (volatility on return distribution) over the 90 days horizon. In different words, 62% of otc stocks are less volatile than Hempstract, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Hempstract is expected to generate 10.16 times more return on investment than the market. However, the company is 10.16 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The DOW is currently generating roughly 0.04 per unit of risk.

Hempstract Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Hempstract's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Hempstract, and traders can use it to determine the average amount a Hempstract's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0225

Good Returns
Average Returns
Small ReturnsHPST
Negative Returns
Estimated Market Risk
  actual daily
 62 %
of total potential
Expected Return
  actual daily
 3 %
of total potential
Risk-Adjusted Return
  actual daily
 1 %
of total potential
Based on monthly moving average Hempstract is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hempstract by adding it to a well-diversified portfolio.

About Hempstract Performance

To evaluate Hempstract OTC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Hempstract generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Hempstract OTC Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Hempstract stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Hempstract's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Hempstract, Inc. produces and sells cannabidiol and cannabigerol solutions in the United States. It offers CBD isolate powder and distillate oil. The company was formerly known as Riverdale Oil and Gas Corporation and changed its name to Hempstract, Inc. in November 2020. Hempstract, Inc. is based in Warden, Washington.

Things to note about Hempstract

Checking the ongoing alerts about Hempstract for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hempstract help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Hempstract Alerts

Equity Alerts and Improvement Suggestions

Hempstract has very high historical volatility over the last 90 days
Hempstract has some characteristics of a very speculative penny stock
Hempstract has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 12.56 K. Net Loss for the year was (4.43 K) with profit before overhead, payroll, taxes, and interest of 1.7 K.
Please check Risk vs Return Analysis. Note that the Hempstract information on this page should be used as a complementary analysis to other Hempstract's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Hempstract OTC Stock analysis

When running Hempstract price analysis, check to measure Hempstract's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hempstract is operating at the current time. Most of Hempstract's value examination focuses on studying past and present price action to predict the probability of Hempstract's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Hempstract's price. Additionally, you may evaluate how the addition of Hempstract to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Is Hempstract's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hempstract. If investors know Hempstract will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hempstract listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Hempstract is measured differently than its book value, which is the value of Hempstract that is recorded on the company's balance sheet. Investors also form their own opinion of Hempstract's value that differs from its market value or its book value, called intrinsic value, which is Hempstract's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hempstract's market value can be influenced by many factors that don't directly affect Hempstract's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hempstract's value and its price as these two are different measures arrived at by different means. Investors typically determine Hempstract value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hempstract's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.